Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-060465
Filing Date
2025-06-18
Accepted
2025-06-18 07:01:11
Documents
22
Period of Report
2025-07-29

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A tm2516079-1_def14a.htm   iXBRL DEF 14A 959389
5 GRAPHIC lg_avadeltm-4clr.jpg GRAPHIC 12977
6 GRAPHIC bc_nonemployee-4c.jpg GRAPHIC 49489
7 GRAPHIC bc_payvshareholder-4c.jpg GRAPHIC 99891
8 GRAPHIC bc_payvsnetincome-4c.jpg GRAPHIC 87783
9 GRAPHIC bc_payvsnetrevenue-4c.jpg GRAPHIC 82498
10 GRAPHIC px_25avadelpxy01pg01-4c.jpg GRAPHIC 401387
11 GRAPHIC px_25avadelpxy01pg02-4c.jpg GRAPHIC 260046
  Complete submission text file 0001104659-25-060465.txt   4471919

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avdl-20241231.xsd EX-101.SCH 7233
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avdl-20241231_def.xml EX-101.DEF 1877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20241231_lab.xml EX-101.LAB 22761
24 EXTRACTED XBRL INSTANCE DOCUMENT tm2516079-1_def14a_htm.xml XML 331379
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37977 | Film No.: 251055111
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)